N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase-Reference-Cited by-同舟云学术

N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase

Published:2016-12 Issue: Volume:96 Page:323-334
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Francis Jeremy S.,Wojtas Ireneusz,Markov Vladimir,Gray Steven J.,McCown Thomas J.,Samulski R. Jude,Bilaniuk Larissa T.,Wang Dah-Jyuu,De Vivo Darryl C.,Janson Christopher G.,Leone Paola

Funder

Bamboo Therapeutics

NIH

Canavan Research Illinois

Ralph & Lois Silver Foundation

Jacob's Cure

Michel J. Fox Foundation

Research to Prevent Blindness

Publisher

Elsevier BV

Subject

Neurology

Reference51 articles.

1. A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice;Ahmed;Mol. Ther.,2013

2. rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System;Ahmed;Mol Ther,2016

3. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation;Baslow;J. Mol. Neurosci.,2003

4. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes;Baslow;J. Mol. Neurosci.,1999

5. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo;Bates;Neuroreport,1996

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials;Neurotherapeutics;2024-07

2. Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS/MS neonatal screening method for the diagnosis of Canavan disease;Molecular Genetics and Metabolism;2024-06

3. Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease;Cell & Bioscience;2024-04-06

4. Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition;ACS Chemical Neuroscience;2024-02-20

5. Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential;Aging and disease;2024